3-octylthio-1,1,1-trifluoro-2-propanone has been researched along with lovastatin in 1 studies
| Studies (3-octylthio-1,1,1-trifluoro-2-propanone) | Trials (3-octylthio-1,1,1-trifluoro-2-propanone) | Recent Studies (post-2010) (3-octylthio-1,1,1-trifluoro-2-propanone) | Studies (lovastatin) | Trials (lovastatin) | Recent Studies (post-2010) (lovastatin) |
|---|---|---|---|---|---|
| 26 | 0 | 5 | 4,828 | 698 | 873 |
| Protein | Taxonomy | 3-octylthio-1,1,1-trifluoro-2-propanone (IC50) | lovastatin (IC50) |
|---|---|---|---|
| Chain A, Antigen Cd11a (p180) | Homo sapiens (human) | 2.4 | |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Homo sapiens (human) | 0.0261 | |
| Integrin beta-2 | Homo sapiens (human) | 3.09 | |
| Intercellular adhesion molecule 1 | Homo sapiens (human) | 3.78 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 8.753 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 10 | |
| Neutrophil elastase | Homo sapiens (human) | 0.027 | |
| Insulin receptor | Rattus norvegicus (Norway rat) | 0.02 | |
| Integrin alpha-L | Homo sapiens (human) | 3.09 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 8.753 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.02 | |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Rattus norvegicus (Norway rat) | 0.0529 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, T; Nakagawa, Y; Potter, PM; Wadkins, RM; Wheelock, CE | 1 |
1 other study(ies) available for 3-octylthio-1,1,1-trifluoro-2-propanone and lovastatin
| Article | Year |
|---|---|
Comparison of benzil and trifluoromethyl ketone (TFK)-mediated carboxylesterase inhibition using classical and 3D-quantitative structure-activity relationship analysis.
Topics: Carboxylesterase; Carboxylic Ester Hydrolases; Enzyme Inhibitors; Humans; Ketones; Quantitative Structure-Activity Relationship | 2009 |